Psilocybin vs. SSRIs: Comparing Treatments for Depression

For decades, SSRIs (selective serotonin reuptake inhibitors) like Prozac, Zoloft, and Lexapro have been the standard treatment for depression. A growing body of research is now studying psilocybin therapy as a different kind of approach — one built around a small number of supervised sessions rather than daily medication — though head-to-head trials so far show a more nuanced picture than "one beats the other."

Learn what actually happens during the ayahuasca ceremony itself — ritual structure, facilitator's role, the purge, and next-morning integration.

In 2021, Imperial College London conducted a randomized, double-blind trial directly comparing two doses of psilocybin (with psychological support) to six weeks of daily escitalopram, a standard SSRI (Carhart-Harris R, et al. N Engl J Med. 2021). On the trial's pre-specified primary endpoint — change in depression score at six weeks — psilocybin was not shown to be statistically superior to escitalopram; the two groups improved by a similar amount. On several secondary measures — including well-being, social functioning, and anhedonia (the ability to feel pleasure) — the psilocybin group showed larger improvements, but secondary findings are hypothesis-generating, not confirmatory. Psilocybin delivered this result across two dosing sessions, versus daily dosing for the SSRI arm, which is itself a meaningful practical difference even without a primary-endpoint win.

Mechanism of Action

SSRIs work by increasing serotonin availability in the brain — essentially adjusting neurotransmitter levels. Psilocybin, however, promotes neuroplasticity — the brain's ability to form new neural connections. This is why psilocybin can produce lasting changes after just 1-2 sessions, while SSRIs require continuous daily dosing and effects disappear when the medication is stopped.

Side Effects

SSRIs commonly cause weight gain, sexual dysfunction, emotional blunting, insomnia, and gastrointestinal issues. Many patients describe feeling "numbed" rather than healed. Psilocybin's side effects are limited to the acute experience (nausea, temporary anxiety) and typically resolve within hours. There is no daily dosing and no withdrawal syndrome.

Treatment Duration

Most SSRI protocols involve months to years of daily medication, with many patients remaining on antidepressants indefinitely. Psilocybin therapy typically involves 1-3 sessions with lasting effects. At Sanctuary Tulum, psilocybin is part of a comprehensive program that creates deep, permanent shifts rather than ongoing symptom management.

SSRIs remain appropriate for some patients, particularly those with contraindications to psilocybin (psychotic spectrum disorders), those who need immediate pharmacological stabilization, or those without access to supervised psilocybin therapy. The ideal approach, as practiced at Sanctuary Tulum, is personalized medicine — matching each patient with the treatment modality most likely to produce lasting healing.

Psilocybin and SSRIs both act on the serotonin system, and combining them is not a simple substitution to be made without medical guidance. A 2025 scoping review of concomitant antidepressant and classic-psychedelic use found that SSRIs and SNRIs can blunt the subjective intensity of a psilocybin session, while other patients on the same medications have reported unpredictable or amplified responses — the interaction is not uniform and is not yet fully mapped (Tap SC. J Psychopharmacol. 2025). This is one of the reasons Sanctuary Tulum does not treat a switch from SSRI to psilocybin as routine: it requires a physician-supervised taper plan coordinated with the client's prescribing doctor, not a unilateral decision by the client. No one should stop a prescribed antidepressant on their own — abrupt discontinuation carries its own withdrawal risks, independent of any plan to explore psilocybin.

The underlying biology helps explain why. Psilocybin's antidepressant effects are thought to involve rapid, activity-dependent structural neuroplasticity — new dendritic spine growth and remodeled neural connections — rather than the sustained receptor-level occupancy that SSRIs rely on (Ly C, et al. Cell Rep. 2018; Weiss F, et al. Brain Sci. 2025). Because SSRIs already saturate serotonin signaling, layering a serotonergic psychedelic on top of an unmodified SSRI dose can dull the acute subjective effects that the therapeutic protocol depends on, or in rarer cases contribute to overstimulation of serotonin receptors. Neither outcome is desirable, which is exactly why any transition plan runs through the prescribing physician and Sanctuary Tulum's medical team together, on a documented timeline, rather than through self-directed discontinuation.

Every prospective guest at Sanctuary Tulum completes a confidential clinical intake and full medical screening before any protocol is scheduled. The intake reviews current medications, medical history, cardiovascular status, mental health history, and where relevant, substance-use pattern. Where a client is currently prescribed SSRIs, SNRIs, MAO inhibitors, benzodiazepines, opioids, or lithium, our medical team plans a documented taper or pause window with the treating physician before any ceremony or high-dose infusion is scheduled. No client is cleared for plant-medicine or advanced regenerative protocols until that clearance is on file.

This protocol is one component of Sanctuary Tulum's integrative residential program. For the broader treatment framework, see the Pouyan Method™ page. For the medically supervised detox side, see the medically supervised luxury detox page. Plant-medicine components are described on the medically supervised ibogaine treatment, ayahuasca ceremony, and 5-MeO-DMT ceremony pages.

Sanctuary Tulum does not guarantee outcomes and does not present any protocol as a cure. Response varies by diagnosis, medication history, adherence to the aftercare plan, and the client's overall clinical picture. Aftercare planning begins in the second half of every residential arc: nutrition and supplement protocols to carry home, a taper or continuation plan for any prescribed medications reviewed at intake, an integration schedule, and referrals to physicians or integrative practitioners in the client's home region.

If this protocol is worth exploring for you or a family member, the next step is a confidential clinical intake. Start with the confidential intake form or reach the clinical team through the contact page. Nothing on this page constitutes medical advice or a clinical determination for any individual. All decisions are made in consultation with the on-site medical team after a full screening.